EUVIMEDEUVIMED entdecken
Crossref

Aggregation of monoclonal and bispecific antibodies during pneumatic tube transport of IV bags in a hospital: Mitigation by polysorbate 80, poloxamer 188, and headspace removal

Parham Parnian, Annette M Medina, Nidia Gonzalez Lopez, Katiria Flores, Lakyn Lucio, Lauren Reist, Mark A Arnold, Stanley C Kwok, Reza Nejadnik

Journal of Pharmaceutical Sciences · 2026-06 · 115 (6) · 104264

DOI: 10.1016/j.xphs.2026.104264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Sciences, 2026-06. Verfasst von Parham Parnian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, USA; Center for Biocatalysis…. Hauptthemen laut MEDLINE: Polysorbates, Antibodies, Monoclonal, Poloxamer, Antibodies, Bispecific. Die Arbeit nennt 56 Literaturangaben. Gefördert von: National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pneumatic tube systems (PTS) are being increasingly used in hospitals to rapidly transport critical packages, but their mechanical stresses raise concerns for the safe transport of protein therapeutics. This study examined the impact of the PTS at the University of Iowa Hospital on protein admixtures of a monoclonal antibody (mAb) and a bispecific antibody (BsAb) prepared in IV-bags and benchmarked it against manual transport and shaking. The PTS ride imposed sharp shocks nearly tenfold higher than either shaking or manual transport. Flow imaging microscopy revealed increased microparticle formation for both proteins, though with distinct profiles. The mAb generated more small aggregates, whereas the BsAb produced fewer yet larger particles. Surfactants reduced particle formation, with Polysorbate 80 (PS80) more effective than poloxamer 188. For BsAb, PS80 lowered microparticles by ∼70% but failed to prevent large particle formation, in contrast to its near-complete protection for mAb. Headspace removal further reduced particle formation, fully preventing the formation of large aggregates when combined with PS80. Size exclusion chromatography revealed no detectable increase in soluble aggregates or monomer loss. These findings show that PTS presents a unique stress profile not replicated by shaking and highlight the need for case-by-case evaluation of PTS compatibility based on protein, container, and excipients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolysorbatesAntibodies, MonoclonalPoloxamerAntibodies, BispecificDrug PackagingProtein AggregatesSurface-Active AgentsParticle SizeExcipients

Stichwörter der Autor:innen

Bispecific antibodyHeadspaceIV bagsMicroparticlesMonoclonal antibodyNanoparticlesPneumatic tube system transportationPoloxamer 188Polysorbate 80Protein aggregation

Substanzen

PolysorbatesAntibodies, MonoclonalPoloxamerAntibodies, BispecificProtein AggregatesSurface-Active AgentsExcipients

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, USA; Center for Biocatalysis and Bioprocessing, University of Iowa, Coralville, USA.
  • Dosage Form Design and Development, BioPharmaceutical Development, R&D, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD, 20878, USA.
  • Injectable Drug Product Development, Product Development and Clinical Supply, Alexion AstraZeneca Rare Disease, New Haven, CT, USA.
  • University of Iowa Health Care, University of Iowa, Iowa City, USA.
  • Center for Biocatalysis and Bioprocessing, University of Iowa, Coralville, USA.
  • Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, USA. Electronic address: reza-nejadnik@uiowa.edu.

Förderung

  • National Science Foundation

Zitieren

APA

Parnian, P., Medina, A. M., Lopez, N. G., Flores, K., Lucio, L., Reist, L., Arnold, M. A., Kwok, S. C., & Nejadnik, R. (2026). Aggregation of monoclonal and bispecific antibodies during pneumatic tube transport of IV bags in a hospital: Mitigation by polysorbate 80, poloxamer 188, and headspace removal. Journal of Pharmaceutical Sciences, 115(6), 104264. https://doi.org/10.1016/j.xphs.2026.104264

Vancouver

Parnian P, Medina AM, Lopez NG, Flores K, Lucio L, Reist L, et al. Aggregation of monoclonal and bispecific antibodies during pneumatic tube transport of IV bags in a hospital: Mitigation by polysorbate 80, poloxamer 188, and headspace removal. Journal of Pharmaceutical Sciences. 2026;115(6):104264. doi:10.1016/j.xphs.2026.104264

BibTeX
@article{Parnian2026,
  author = {Parnian, Parham and Medina, Annette M and Lopez, Nidia Gonzalez and Flores, Katiria and Lucio, Lakyn and Reist, Lauren and Arnold, Mark A and Kwok, Stanley C and Nejadnik, Reza},
  title = {Aggregation of monoclonal and bispecific antibodies during pneumatic tube transport of IV bags in a hospital: Mitigation by polysorbate 80, poloxamer 188, and headspace removal},
  journal = {Journal of Pharmaceutical Sciences},
  year = {2026},
  volume = {115},
  number = {6},
  pages = {104264},
  doi = {10.1016/j.xphs.2026.104264}
}
Kostenlos starten →